direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Page Content

2020 [1] | 2019 [2] | 2018 [3] | 2017 [4] | 2016 [5] | 2015 [6] | 2014 [7] | 2013 [8] | 2012 [9] | 2011 [10] | 2010 [11] | 2009 [12] | 2008 [13] | 2007 [14] | 2006 [15] | 2005 [16] | 2004 [17] | 2003 [18] | 2002 [19]

Lectures 2014

Lupe [20]
Lupe [21]

Diagnosis Related Groups in Europe: Adaptations and trends [22]
Diagnosis Related Groups en Europe: Adaptations et tendances [23]
W. Quentin
Genf 26.11.2014

“Living up to Improved Performance” - The role of international projects [24]
Britta Zander
Eupha 22.11.2014

Lupe [25]

Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland) [26]
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014

Lupe [27]

Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane? [28]
Alexander Geissler, Dr.
Dubrovnik 14.11.2014

Lupe [29]

DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it [30]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014

Lupe [31]

Medical devices: a taxonomy suitable for HTA [32]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [33]

Medical devices: differences vs. other technologies, especially pharmaceuticals [34]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [35]

Inequalities in Health and Health Care [36]
Martin Siegel, Dr.
Dresden 22.09.2014

Lupe [37]

Exploring barriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment [38]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 17.09.2014

Lupe [39]

The German health system: basics and some comparisons with other countries [40]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [41]

From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011 [42]
Martin Siegel, Dr.
Dublin 16.07.2014

Lupe [43]

Towards a taxonomy of medical devices in the logic of HTA and economic evaluations rather than marketing authorization [44]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014

A taxonomy of medical devices in the logic of HTA [45]
Dimitra Panteli
Washington 16.06.2014

Equity considerations among HTA agencies –current practice and ways forward [46]
Dimitra Panteli
Washington 16.06.2014

The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries [47]
Dimitra Panteli
Washington 16.06.2014

The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries [48]
Dimitra Panteli
Washington 16.06.2014

Lupe [49]

Intoduction to the healthcare ecosystem and cost factors [50]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014

Lupe [51]

The Health Systems and Policy Monitor (HSPM) [52]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014

Lupe [53]

The European Observatory on Health Systems and Policies [54]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014

Lupe [55]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II) [56]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [57]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I) [58]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [59]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview [60]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 14.04.2014

Lupe [61]

Health care reform and pharmaceutical policies in Germany [62]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [63]

Addressing emerging patient needs:from free choice to integrated care [64]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 21.03.2014

Lupe [65]

Hospital payment and DRGs in Germany: The G-DRG system [66]
Wilm Quentin, Dr. med MSc HPPF
Warsaw 18.03.2014

Lupe [67]

The effect of continuity of ambulatory care on hospitalizations in patients with heart failure [68]
Verena Vogt
Munich 17.03.2014

Lupe [69]

The Latvian Health System [70]
Uldis Mittenbergs & Wilm Quentin
Brussels 07.03.2014

Lupe [71]

Regulation and governance of providers (especially hospitals) [72]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [73]

DRGs in Europe: towards transparency, efficiency, and quality of hospital care? [74]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [75]

Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations [76]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014

Lupe [77]

The financing function: Raising, pooling and allocating resources [78]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [79]

Differences in health care structure and incentives – do they worsen or reduce health inequalities? (… and a framework to examine access to health care …) [80]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [81]

Health system reforms in times of crisis: EU countries [82]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

------ Links: ------

Zusatzinformationen / Extras

Quick Access:

Schnellnavigation zur Seite über Nummerneingabe

Auxiliary Functions

Copyright TU Berlin 2008